Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May-Jun;42(3):422-30.
doi: 10.1590/S1677-5538.IBJU.2015.0095.

Metabolic syndrome and prostatic disease: potentially role of polyphenols in preventive strategies. A review

Tommaso Castelli  1 , Giorgio Ivan Russo  1 , Giulio Reale  1 , Salvatore Privitera  1 , Mario Chisari  1 , Eugenia Fragalà  1 , Vincenzo Favilla  1 , Sebastiano Cimino  1 , Giuseppe Morgia  1
Affiliations
Review

Metabolic syndrome and prostatic disease: potentially role of polyphenols in preventive strategies. A review

Tommaso Castelli et al. Int Braz J Urol. 2016 May-Jun.

Abstract

Benign prostatic hyperplasia and prostate cancer are two common urological diseases of the elderly. Scientific community has always looked for a link that could explain the correlation between the two diseases and the role of chronic inflammation in the pathogenesis of BPH and PCa. As shown by the reports of the two diseases relationship with oxidative stress and metabolic syndrome, the use of compounds with antioxidant action could therefore affect both the symptoms and their onset. Polyphenols appear to act not only against oxidative stress but also at different levels. The aim of this review is to evaluate the role of the most important polyphenols on these two urological diseases. As antioxidants these compounds seems to have a direct action on the cell cycle and hormone function, important for both prostate cancer and BPH. Despite a large number of articles about the relationship of the polyphenols with prostate cancer, very little evidence exists for BPH. Additional clinical trials or meta-analysis are necessary on this topic.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

None declared.

Figures

Figure 1
Figure 1. Flow Diagram of included studies.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including be-nign prostatic obstruction. Eur Urol. 2013;64:118–140. - PubMed
    1. Minutoli L, Altavilla D, Marini H, Rinaldi M, Irrera N, Pizzino G, et al. Inhibitors of apoptosis pro-teins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene. 19J Biomed Sci. 2014;21 - PMC - PubMed
    1. Morgia G, Cimino S, Favilla V, Russo GI, Squadrito F, Mucciardi G, et al. Effects of Serenoa re-pens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of “FLOG” (Flogosis and Profluss in Prostatic and Genital Disease), a multicen-tre Italian study. Int Braz J Urol. 2013;39:214–221. - PubMed
    1. Sebastiano C, Vincenzo F, Tommaso C, Giuseppe S, Marco R, Ivana C, et al. Dietary patterns and prostatic diseases. Front Biosci (Elite Ed) 2012;4:195–204. - PubMed
    1. Tang J, Yang J. Etiopathogenesis of benign prostatic hypeprlasia. Indian J Urol. 2009;25:312–317. - PMC - PubMed

MeSH terms